Non-Human Primate (NHP) Food Effect & Drug-Drug Interaction (DDI) related In Vivo Pharmacokinetic (PK) Service

Non-Human Primate Food Effect & DDI (Drug-Drug Interaction) In Vivo PK Studies: Accelerate Your Drug Development Process! Are you currently facing long drug development cycles, or challenges in obtaining reliable and predictive preclinical data? Our NHP In Vivo PK Studies help you de-risk and accelerate your drug discovery process by providing critical data on how a new drug behaves in a living system that is highly relevant to humans. We achieve this through advanced, customized study designs in a premier preclinical setting.

Introduction of NHP Food Effect & DDI In Vivo PK Studies

What Our Service Is

Creative Biolabs' In Vivo PK Profiling service for NHPs is a specialized offering designed to generate critical data on a drug's behavior within a living system. This service focuses on understanding a drug's pharmacokinetics—how it is absorbed, distributed, metabolized, and excreted—in a model that is genetically, physiologically, and metabolically similar to humans. This exceptional similarity makes NHPs the gold standard for bridging the gap between foundational studies and human clinical trials, offering superior predictive power. This specialized service provides critical insights for two key application scenarios:

• Food Effect Studies: We determine how the presence of food in the stomach and digestive tract affects a drug's absorption and bioavailability. The physiological changes that occur with food consumption—such as fluctuating pH and altered gastric emptying—can significantly impact a drug's effectiveness, making this an essential regulatory and safety assessment.
• DDI Studies: We assess how a new drug interacts with other medications. This is crucial for safety and efficacy, as co-administration can lead to decreased effectiveness or dangerous toxicity.

Why Choose Us?

The value of our service lies in its ability to directly address the critical pain points of preclinical drug development. Compared to rodent models, which often fail to accurately predict human outcomes, our NHP studies provide data with enhanced translational value. This reduces the risk of costly and time-consuming clinical trial failures, allowing you to make informed decisions earlier in your pipeline. By partnering with Creative Biolabs, you gain access to a service that provides the high-quality, predictive data needed to streamline your project and move your therapeutic candidates forward with confidence.

Fig.1 Key physiological alterations in the gastrointestinal tract post food intake.¹

Key Benefits of Our Service

Our Non-Human Primate Food Effect & DDI PK Studies are defined by a set of distinct advantages that set Creative Biolabs apart as your ideal partner.

• Exceptional Translational Value: Utilizing NHPs provides more reliable data for predicting human outcomes compared to less translatable models. Published Data consistently demonstrates that NHP models offer a superior physiological and metabolic match, significantly reducing the risk of failures later in the development process.
• Rapid Response and TAT: We understand the urgency of drug development. Our streamlined processes and dedicated team ensure a fast response to your inquiries and a rapid turnaround time for your studies. We pride ourselves on providing data quickly and efficiently without compromising on quality or accuracy.
• Robust NHP Resources: Our extensive network and rigorous animal care protocols guarantee access to healthy, well-characterized NHP cohorts, ensuring the consistency and reliability of your study data.
• Fully Customizable Study Designs: We don't believe in a one-size-fits-all approach. Every study is custom-tailored to meet the specific needs of your drug development program, from different dosing routes and dose levels to optimized study durations.
• Comprehensive and In-Depth Reporting: Our final reports provide a detailed and transparent overview of the study. Beyond just raw data, we provide expert analysis and interpretation, helping you understand the implications of the findings and make data-driven decisions.

How Creative Biolabs' NHP Food Effect & DDI In Vivo PK Studies Can Assist Your Project?

Key Deliverables

Upon completion of your study, you will receive a comprehensive data package that includes:

• Final Study Report: A detailed document summarizing the study's purpose, methods, and results, suitable for regulatory submissions.
• Raw Data: All raw bioanalytical data files, including chromatograms and concentration-time tables.
• PK Analysis: A complete pharmacokinetic data analysis report, including calculated parameters, model annotations, and high-quality figures.
• Archived Samples: We also offer the option to archive remaining biological samples for future analysis.

Capabilities & Partnerships

Service-Specific Data

• Annual Sample Size: 50000+
• Typical Turnaround Time: 8-12 weeks
• Method Validation Pass Rate: 95%+

Our Valued Partners

Frequently Asked Questions

Contact Us

Creative Biolabs is a leader in preclinical drug development, offering comprehensive and customizable solutions to accelerate your research. Our Non-Human Primate Food Effect & DDI PK Studies provide the high-quality, predictive data you need to confidently move your therapeutic candidates from the lab to the clinic. Contact Our Team for More Information and to Discuss Your Project.